Stereotactic Body Radiation Therapy for Head and Neck Tumor: Disease Control and Morbidity Outcomes
Open Access
- 1 January 2011
- journal article
- Published by Oxford University Press (OUP) in Journal of Radiation Research
- Vol. 52 (1), 24-31
- https://doi.org/10.1269/jrr.10086
Abstract
We evaluated the efficacy and safety of stereotactic body radiation therapy (SBRT) for patients with head and neck tumors. From April 2005 through April 2008, 34 patients with head and neck tumors were treated with CyberKnife SBRT. Twenty-one of them had prior radiotherapy. Treatment sites were orbit (n = 7), cervical lymph nodes (n = 6), nasopharynx (n = 5), oropharynx (n = 4) and others (n = 12). The prescribed dose ranged from 19.5 to 42 Gy (median, 30 Gy) in 3–8 fractions for consecutive days. The target volume ranged from 0.7 to 78.1 cm3 (median, 11.6 cm3). The median follow-up was 16 months. Treatment was well tolerated without significant acute complications in any cases. Complete response rate and partial response rate were 32.4% and 38.6%, respectively. The overall survival rates were 70.6% and 58.3% at 12 and 24 months, respectively. The overall survival was better in patients without prior radiotherapy within the previous 24 months or in case of smaller target volume. Six patients suffered severe late complications. All these patients had prior radiotherapy, and 2 of them developed massive hemorrhage in the pharynx and both died of this complication 5 and 28 months, respectively, after SBRT. Our preliminary results suggest that SBRT is an effective treatment modality for head and neck tumors. However, re-irradiation has significant risk of severe and even fatal late complications in the form of necrosis and hemorrhage in re-irradiated areas.Keywords
This publication has 28 references indexed in Scilit:
- Fractionated Stereotactic Radiotherapy as Reirradiation for Locally Recurrent Head and Neck CancerInternational Journal of Radiation Oncology*Biology*Physics, 2009
- Stereotactic Body Radiation Therapy for Primary, Recurrent, and Metastatic Tumors in the Head-and-Neck RegionInternational Journal of Radiation Oncology*Biology*Physics, 2009
- Combined Modality Therapy in the Elderly PopulationCurrent Treatment Options in Oncology, 2009
- Radiotherapy plus Cetuximab for Squamous-Cell Carcinoma of the Head and NeckThe New England Journal of Medicine, 2006
- Patterns of failure, prognostic factors and survival in locoregionally advanced head and neck cancer treated with concomitant chemoradiotherapy: a 9-year, 337-patient, multi-institutional experienceAnnals of Oncology, 2004
- Postoperative Concurrent Radiotherapy and Chemotherapy for High-Risk Squamous-Cell Carcinoma of the Head and NeckThe New England Journal of Medicine, 2004
- Postoperative Irradiation with or without Concomitant Chemotherapy for Locally Advanced Head and Neck CancerThe New England Journal of Medicine, 2004
- The CyberKnife Stereotactic Radiosurgery System: Description, Installation, and an Initial Evaluation of Use and FunctionalityNeurosurgery, 2003
- Robotics and Radiosurgery – The CyberknifeStereotactic and Functional Neurosurgery, 2001
- Image-guided Robotic RadiosurgeryNeurosurgery, 1999